Pricing Supplement dated March 2, 1995                          Rule 424(b)(3)
(To Prospectus dated January 8, 1993 and                     File No. 33-54870
Prospectus Supplement dated February 15, 1995)

                                    NATIONWIDE HEALTH PROPERTIES, INC.
                                       Medium-Term Note - Fixed Rate
_________________________________________________________________

Face Amount: $3,000,000
Trade Date: March 2, 1995
Issue Price: 100%
Original Issue Date: March 9, 1995
Interest Rate: 9.05%
Net Proceeds to Issuer: $2,977,500
Interest Payment Dates: April 1, October 1
Agent's Commission: .75%
Regular Record Dates: March 17, September 16
Name of Agent: Goldman, Sachs & Co.
Stated Maturity Date: March 9, 2015
Agent acting in the capacity indicated below:
 [X] As Agent
 [ ] As Principal
Denominations (if other than $1000 and integral multiples
thereof):_______________
_________________________________________________________________

Day Count Convention:
 [X] 30/360 for the period from March 9, 1995 to March 9, 2015
 [ ] Actual/360 for the period from           to
 [ ] Actual/Actual for the period from        to
 [ ] Other (see attached)                     to

Redemption:
 [ ] The Notes cannot be redeemed prior to the Stated Maturity
      Date.
 [X] The Notes may be redeemed prior to Stated Maturity Date.
      Initial Redemption Date:  March 9, 2002
      Initial Redemption Percentage:  100%
      Annual Redemption Percentage Reduction:      % until
       Redemption Percentage is 100% of the Principal Amount.

Repayment:
 [X] The Notes cannot be repaid prior to the Stated Maturity Date
     (except pursuant to the Redemption option above).
 [ ] The Notes can be repaid prior to the Stated Maturity Date at
      the option of the holder of the Notes.
      Optional Repayment Date(s):  
      Repayment Price:   

Original Issue Discount: [ ] Yes  [X] No
        Total Amount of OID:
        Yield to Maturity:
        Initial Accrual Period:

Form: [X] Book-entry  [ ] Certificated
                                  _______________________________________

Goldman, Sachs & Co.                       Merrill Lynch & Co.